Literature DB >> 1563325

Effect of intraduodenal administration of 23-methyl-UDCA diastereoisomers on bile flow in hamsters.

C Clerici1, G Dozzini, E Distrutti, G Gentili, B M Sadeghpour, B Natalini, R Pellicciari, R Rizzoli, A Roda, M A Pelli.   

Abstract

3 alpha,7 beta-Dihydroxy-23-methyl-5 beta-cholan-24-oic acid (MUDCA) and its two diastereoisomers, alpha- and beta-MUDCA, were infused intraduodenally in biliary fistula hamsters in order to evaluate the effect on bile flow and their hepatic biotransformation processes compared with the natural analog ursodeoxycholic acid (UDCA). In addition, the corresponding glycine conjugates were compared. The bile acids were administered at different doses (0.7-6 mumol/min/kg) over periods of 90 min. The results indicate that the racemic mixture exhibits a potent choleretic effect at both low and high doses, while the two individual diastereoisomers show this effect only at high doses. The presence of a C-23 methyl group in the side chain prevents hepatic amidation and alternative conjugations occur, such as glucuronidation, in order to facilitate their biliary secretion. Biotransformation of the methyl derivatives of UDCA occurred mainly by conversion to more polar glucuronide conjugates. There was little alteration to the molecule and, unlike UDCA, very little amidation occurred. These data indicate that the presence of a C-23 methyl group prevents the usual side-chain amidation common to the most naturally occurring bile acids and that glucuronidation is a requisite for efficient biliary excretion.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1563325     DOI: 10.1007/bf01296441

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  17 in total

1.  Effect of ursodeoxycholic acid treatment on alanine aminotransferase and gamma-glutamyltranspeptidase serum levels in patients with hypertransaminasemia. Results from a double-blind controlled trial.

Authors:  S Bellentani; G Tabarroni; T Barchi; I Ferretti; N Fratti; E Villa; F Manenti
Journal:  J Hepatol       Date:  1989-01       Impact factor: 25.083

2.  23-Methyl-3 alpha,7 beta-dihydroxy-5 beta-cholan-24-oic acid: dose-response study of biliary secretion in rat.

Authors:  A Roda; R Aldini; B Grigolo; P Simoni; E Roda; R Pellicciari; P L Lenzi; B Natalini
Journal:  Hepatology       Date:  1988 Nov-Dec       Impact factor: 17.425

Review 3.  Ursodeoxycholic acid for chronic liver diseases.

Authors:  M Podda; C Ghezzi; P M Battezzati; E Bertolini; A Crosignani; M L Petroni; M Zuin
Journal:  J Clin Gastroenterol       Date:  1988       Impact factor: 3.062

4.  Ursodeoxycholic acid in primary biliary cirrhosis: results of a controlled double-blind trial.

Authors:  U Leuschner; H Fischer; W Kurtz; S Güldütuna; K Hübner; A Hellstern; M Gatzen; M Leuschner
Journal:  Gastroenterology       Date:  1989-11       Impact factor: 22.682

5.  Is ursodeoxycholic acid an effective treatment for primary biliary cirrhosis?

Authors:  R Poupon; Y Chrétien; R E Poupon; F Ballet; Y Calmus; F Darnis
Journal:  Lancet       Date:  1987-04-11       Impact factor: 79.321

6.  Influence of bile acid structure on bile flow and biliary lipid secretion in the hamster.

Authors:  D Gurantz; A F Hofmann
Journal:  Am J Physiol       Date:  1984-12

7.  Class separation of bile lipids by thin-layer chromatography.

Authors:  M Nakagaki; F Nakayama
Journal:  J Chromatogr       Date:  1979-09-21

8.  Bile acid glycine and taurine conjugates in serum of patients with primary biliary cirrhosis: effect of ursodeoxycholic treatment.

Authors:  Y Chretien; R Poupon; M F Gherardt; O Chazouilleres; D Labbe; A Myara; F Trivin
Journal:  Gut       Date:  1989-08       Impact factor: 23.059

9.  Hypercholeresis induced by norchenodeoxycholate in biliary fistula rodent.

Authors:  K R Palmer; D Gurantz; A F Hofmann; L M Clayton; L R Hagey; S Cecchetti
Journal:  Am J Physiol       Date:  1987-02

10.  Development of a sensitive enzyme immunoassay for plasma and salivary steroids.

Authors:  A Roda; S Girotti; S Lodi; S Preti
Journal:  Talanta       Date:  1984-10       Impact factor: 6.057

View more
  1 in total

1.  Different protective effects of tauroursodeoxycholate, ursodeoxycholate, and 23-methyl-ursodeoxycholate against taurolithocholate-induced cholestasis.

Authors:  U Baumgartner; J Schölmerich; M Sellinger; M Reinhardt; G Ruf; E H Farthmann
Journal:  Dig Dis Sci       Date:  1996-02       Impact factor: 3.199

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.